Search

Your search keyword '"Curran W.J."' showing total 314 results

Search Constraints

Start Over You searched for: Author "Curran W.J." Remove constraint Author: "Curran W.J." Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
314 results on '"Curran W.J."'

Search Results

3. Innovative Widefield Volumetric Arc Radiation Therapy (VMAT) Approach to Simultaneously Treat Extensive Skin Field Cancerization (ESFC) + In-Field Keratinocyte Carcinoma (KC) in Australian Patients: Report with 12 Month Follow-Up

5. Surgical Outcomes for Early-Stage Non-Small Cell Lung Cancer at Facilities With Stereotactic Body Radiation Therapy Programs

6. CA209-9KY: Phase II Study of IMRT Re-Irradiation and Concurrent/Adjuvant Nivolumab (Nivo) in Patients With Loco Regionally Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma (HNSCC) ― Toxicity and Quality of Life (QoL) Results

7. 1503O Clinical and scientific impact of National Cancer Institute: Sponsored clinical trial network group treatment trials

15. Impact of Postoperative Radiation Therapy Timing on Survival in HPV-Associated Oropharyngeal Squamous Cell Carcinoma

20. Radiomic Biomarkers Evaluation of the High Dose Arm of RTOG 0617

21. Radiomic Analysis of Radiation Induced Fibrosis Following Stereotactic Body Radiation Therapy

25. A Multi-institutional Analysis of Patterns of Salvage Therapy for Leptomeningeal Disease after Surgical Resection and Radiosurgery for Brain Metastases

32. Survival Advantage to Combined Modality Therapy Seen in Multiple Subgroups Within Anaplastic Thyroid Carcinoma: A Propensity-Score Matched Analysis of the National Cancer Data Base

36. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blocker use During Stereotactic Body Radiation Therapy Associated with Decreased Pneumonitis: A Multi-center Analysis

38. Patterns of Failure and Outcomes Based On Management of Leptomeningeal Disease after Surgical Resection and Radiosurgery for Brain Metastases: A Multi-Institutional Analysis

39. Safety Evaluation of Nivolumab Concomitant With Platinum-Based Chemoradiation therapy for Intermediate and High-Risk Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504

41. Next Generation Sequencing and Clinical Outcomes of Lung Adenocarcinomas Treated With Stereotactic Body Radiation Therapy

43. Higher Radiation Dose to Immune System is Correlated With Poorer Survival in Patients With Stage III Non–small Cell Lung Cancer: A Secondary Study of a Phase 3 Cooperative Group Trial (NRG Oncology RTOG 0617)

44. KRAS Mutant Non–small Cell Lung Cancer is Associated With Increased Risk of Salvage Whole Brain Radiation after Stereotactic Radiosurgery for Brain Metastases

45. External Validity of a Nomogram Predicting Risk of 6-Month and 9-Month Distant Brain Failure After Initial Stereotactic Radiosurgery Alone for Brain Metastases in an Independent Multi-institutional Patient Cohort

48. Long-Term Results of RTOG 0617: A Randomized Phase 3 Comparison of Standard Dose Versus High Dose Conformal Chemoradiation Therapy +/- Cetuximab for Stage III NSCLC

Catalog

Books, media, physical & digital resources